SEC 13F Intelligence

Managers / Q2 2021 · view latest →

PenderFund Capital Management Ltd.

CIK 0001706164 · SUITE 1830, 1066 W. HASTINGS STREET, VANCOUVER, A1, V6E 3X2 · 6046881511

Reported Value
$427M
Q2 2021
Positions
88
Filings on Record
32
2019–present window
Filed
Aug 13, 2021
original filing

Summary

Penderfund Capital Management Ltd. reported $427M in U.S.-listed holdings across 88 positions for Q2 2021.

Its largest position, Paratek Pharmaceuticals, represents 5.8% of the portfolio.

Compared with Q1 2021, the fund opened 30 new positions and exited 34.

Portfolio Metrics

Turnover
+21.3%
vs prior filed quarter
Top-10 Concentration
+36.5%
share of reported value
Largest Position
+5.8%
Paratek Pharmaceuticals
New / Exited
30 / 34
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $302MQ4 ’18Q1 ’19: $344MQ2 ’19: $280MQ3 ’19: $297MQ4 ’19: $356MQ4 ’19Q1 ’20: $320MQ2 ’20: $370MQ3 ’20: $360MQ4 ’20: $393MQ4 ’20Q1 ’21: $412MQ2 ’21: $427MQ3 ’21: $383MQ4 ’21: $441MQ4 ’21Q1 ’22: $408MQ2 ’22: $362MQ3 ’22: $320MQ1 ’23: $318,441Q1 ’23Q2 ’23: $321,680Q3 ’23: $333,695Q1 ’24: $378MQ2 ’24: $364MQ2 ’24Q3 ’24: $434MQ4 ’24: $465MQ1 ’25: $514MQ2 ’25: $367MQ2 ’25Q3 ’25: $593MQ4 ’25: $635MQ1 ’26: $639Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 51.9%US DOMESTIC: 24.8%Other: 10.0%ADR: 6.5%GLOBAL: 6.1%Other: 0.7%
  • Common Stock · 51.9% · $222M
  • US DOMESTIC · 24.8% · $106M
  • Other · 10.0% · $43M
  • ADR · 6.5% · $28M
  • GLOBAL · 6.1% · $26M
  • Other · 0.7% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TRICIDA INCNEW+28.41M28.41M+$13M$13M
INTREXON CORPNEW+10.00M10.00M+$11M$11M
0J7QIAC INTERACTIVECORPNEW+34.7K34.7K+$7M$7M
KARYOPHARM THERAPEUTICS INCNEW+3.00M3.00M+$4M$4M
VMEO*VIMEO INCNEW+56.4K56.4K+$3M$3M
BABAALIBABA GROUP HLDG LTDNEW+8.9K8.9K+$3M$3M
KLR1USDKALEYRA INCNEW+138.9K138.9K+$2M$2M
INFINERA CORPNEW+1.00M1.00M+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

47 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1PARATEK PHARMACEUTICALS INCNOTE 4.750% 5/05.76%$25M21.06M
2BURFORD CAP LTDORD SHS5.03%$22M1.67M
3INTERCEPT PHARMACEUTICALS INNOTE 3.250% 7/0 · NOTE 2.000% 5/13.78%$16M16.11M
4ZZILLOW GROUP INChistory →CL C CAP STK3.62%$15M102.1K
5SFIXSTITCH FIX INChistory →COM CL A3.62%$15M206.7K
6BIDUNBAIDU INChistory →SPON ADR REP A3.61%$15M60.9K
7TRICIDA INCNOTE 3.500% 5/13.14%$13M28.41M
8KKRKKR & CO INChistory →COM3.04%$13M177.0K
9SSNCSS&C TECHNOLOGIES HLDGS INChistory →COM2.92%$12M139.6K
10MAXRUSDMAXAR TECHNOLOGIES INChistory →COM2.88%$12M247.8K
11PARPAR TECHNOLOGY CORPhistory →COM2.85%$12M140.5K
12CLDRCLOUDERA INChistory →COM2.66%$11M578.4K
13IBKRINTERACTIVE BROKERS GROUP INhistory →COM CL A2.56%$11M134.0K
14INTREXON CORPNOTE 3.500% 7/02.53%$11M10.00M
15AVNWAVIAT NETWORKS INChistory →COM2.47%$11M260.1K
16XYZSQUARE INChistory →CL A2.45%$10M34.6K
17SHIP FIN INTL LTDNOTE 4.875% 5/02.43%$10M8.66M
18FLEXION THERAPEUTICS INCNOTE 3.375% 5/02.39%$10M9.00M
19LIBERTY LATIN AMERICA LTDCOM CL A · COM CL C2.37%$10M584.3K
20EGANEGAIN CORPhistory →COM2.36%$10M708.2K
21OPKO HEALTH INCNOTE 4.500% 2/12.31%$10M6.00M
22JDJD.COM INChistory →SPON ADR CL A2.27%$10M98.1K
23SSR MNG INCNOTE 2.500% 4/02.22%$9M6.25M
24UTIUNIVERSAL TECHNICAL INST INChistory →COM2.21%$9M1.18M
25EBIXEUREBIX INChistory →COM2.03%$9M205.9K
26TPLTEXAS PACIFIC LAND CORPORATIhistory →COM1.99%$8M4.3K
27SHSPSHARPSPRING INChistory →COM1.94%$8M395.7K
28ACCELERATE DIAGNOSTICS INCNOTE 2.500% 3/11.84%$8M9.56M
29FTSI1USDFTS INTERNATIONAL INChistory →COM NEW CL A1.82%$8M222.0K
30BHCBAUSCH HEALTH COS INChistory →COM1.74%$7M204.7K
31HHC*HOWARD HUGHES CORPhistory →COM1.73%$7M61.2K
320J7QIAC INTERACTIVECORPhistory →COM1.55%$7M34.7K
33EAGLE BULK SHIPPING INCNOTE 5.000% 8/01.45%$6M3.58M
34TWTRUSDTWITTER INChistory →COM1.26%$5M63.2K
35FLRFLUOR CORPhistory →COM1.09%$5M211.7K
36FIREEYE INCNOTE 0.875% 6/00.99%$4M3.00M
37BROOKFIELD ASSET MGMT INCCL A LTD VT SH0.92%$4M62.0K
38KARYOPHARM THERAPEUTICS INCNOTE 3.000%10/10.88%$4M3.00M
39INFINERA CORPNOTE 2.500% 3/0 · NOTE 2.125% 9/00.85%$4M2.13M
40VMEO*VIMEO INCCOMMON STOCK0.80%$3M56.4K
41MIGAMICROSTRATEGY INCCL A NEW0.62%$3M3.2K
42BABAALIBABA GROUP HLDG LTDSPONSORED ADS0.59%$3M8.9K
43KLR1USDKALEYRA INCCOM0.49%$2M138.9K
44SOCIAL CAPITAL HEDOSOPHA HLDSHS CL A0.47%$2M158.3K
45NOCNORTHROP GRUMMAN CORPCOM0.42%$2M4.0K
46BRANDYWINEGBL GBL INCM OPP FCOM0.37%$2M100.0K
47LENDINGTREE INCNOTE 0.625% 6/00.34%$1M1.00M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$639M253May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$635M219Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$593M207Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$367M142Aug 14, 2025RESTATEMENTchanges · EDGAR ↗
Q1 2025$514M142May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$465M129Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$434M137Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$364M126Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$378M116May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023Under review105Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$333,695112Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$321,680114Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$318,441130May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review140Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$320M179Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$362M179Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$408M172May 17, 202213F-HRchanges · EDGAR ↗
Q4 2021$441M157Feb 16, 202213F-HRchanges · EDGAR ↗
Q3 2021$383M140Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$427M88Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$412M92May 10, 202113F-HRchanges · EDGAR ↗
Q4 2020$393M81Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$360M70Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$370M71Aug 17, 202013F-HRchanges · EDGAR ↗
Q1 2020$320M57Apr 27, 202013F-HRchanges · EDGAR ↗
Q4 2019$356M56Feb 5, 202013F-HRchanges · EDGAR ↗
Q3 2019$297M64Oct 29, 201913F-HRchanges · EDGAR ↗
Q2 2019$280M67Jul 31, 2019RESTATEMENTchanges · EDGAR ↗
Q1 2019$344M69Apr 23, 201913F-HRchanges · EDGAR ↗
Q4 2018$302M70Jan 24, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.